Elevance Health (ELV) Stock Rallies As Q3 Results Tighten Margin Focus

Elevance Health just posted its Q3 2026 scorecard and the stock has shrugged off any hesitation. Shares are up 2.6% today to about US$445 even as earnings per share of US$6.30 sit below the prior quarter and net income is US$1.37b on more than US$51b of revenue. That is the sentiment clash investors need to watch. Short term traders are cheering the raised 2026 adjusted earnings guidance and the promise of at least 12% adjusted EPS growth in 2027, while the actual quarterly profit squeeze...